MedTrace Logo

Gender, Obesity, C-Reactive Protein, and Oxidative Stress

NCT00079963 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 396

Last updated 2017-09-27

No results posted yet for this study

Summary

This randomized placebo-controlled trial will test whether supplementing with vitamins C and E can lower markers of inflammation and oxidative stress in healthy adults. We will examine whether one antioxidant vitamin is more effective than another, and whether gender or body fat influence the treatment effects. We will also determine whether gender, body fat, or menopausal status are associated with baseline concentrations of inflammation and oxidative stress markers.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin C

1000 mg/day

DIETARY_SUPPLEMENT

Vitamin E

800 IU/day

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • University of California, Berkeley

    collaborator OTHER

  • Kaiser Permanente

    collaborator OTHER

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    lead NIH

Principal Investigators

  • Gladys Block, Ph.D. · University of California at Berkeley

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2008-03-24
Completion
2008-03-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00079963 on ClinicalTrials.gov